Pharmacological approaches to regulate neutrophil activity

Seminars in Immunopathology

Volumn 35, Issue 4, 2013, Pages 395-409

  Tintinger, G R ^a   Anderson, R ^a   Feldman, C ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cyclic AMP elevating agents; Cytokines; Interleukin 17; Leukotriene B4; Macrolides; Proteinases

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ADRENALIN; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR1 ANTAGONIST; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; CORTICOSTEROID; ELUBRIXIN; FENOTEROL; FORMOTEROL; ITRACONAZOLE; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; MACROLIDE; MONOCLONAL ANTIBODY; MONTELUKAST; NAVARIXIN; NORADRENALIN; POSACONAZOLE; PRANLUKAST; PROSTAGLANDIN E2; ROFLUMILAST; SALBUTAMOL; SALMETEROL; UNCLASSIFIED DRUG; ZAFIRLUKAST;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMA; ATHEROSCLEROSIS; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BULLOUS PEMPHIGOID; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CELL SURVIVAL; CHRONIC GRANULOMATOUS DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHURG STRAUSS SYNDROME; CROHN DISEASE; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DEGRANULATION; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; LEUKOCYTE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MEDIATOR RELEASE; MICROSCOPIC POLYANGIITIS; NAUSEA; NEUTROPHIL; NEUTROPHIL GRANULE; OXIDATIVE STRESS; PANBRONCHIOLITIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSORIASIS; PSORIASIS VULGARIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SEPTIC SHOCK; SEVERE NEUTROPHILIC ASTHMA; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT; UVEITIS; WEGENER GRANULOMATOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 84879687212     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-013-0366-8     Document Type: Review

References (102)

1. 2O reveals a human neutrophil lifespan of 5.4 days. Blood 116(4):625-627
2. Milot E, Filep JG (2011) Regulation of neutrophil survival/apoptosis by Mcl-1. Sci World J 11:1948-1962
3. Cassatella MA (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 73:369-509
4. de Kleijn S, Kox M, Sama IE, Pillay J, van Diepen A, Huijnen MA, van der Hoeven JG, Ferwerda G, Hermans PWM, Pickkers P (2012) Transcriptome kinetics of circulating neutrophils during human experimental endotoxemia. PLoS One 7(6):e38255
5. Sabroe I, Chilvers ER, Whyte MKB (2006). In: Laurent GS, Shapiro SD (eds), Encyclopedia of respiratory medicine. Academic Press, Boston. pp. 547-551
6. Quint JK, Wedzicha JA (2007) The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 119(5):1065-1071
7. Nakagome K, Nagata M (2011) Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx 38(5):555-563
8. Welte T, Groneberg DA (2006) Asthma and COPD. Exp Toxicol Pathol 57(Suppl 2):35-40
9. Simpson JL, Scott RJ, Boyle MJ, Gibson PG (2005) Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 172(5):559-565
10. Fahy JV (2009) Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 6(3):256-259
11. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30:459-489
12. Tam A, Sin DD (2012) Pathobiologic mechanisms of chronic obstructive pulmonary disease. Med Clin N Am 96(4):681-698
13. Downey DG, Bell SC, Elborn JS (2009) Neutrophils in cystic fibrosis. Thorax 64(1):81-88
14. Papayannopoulos V, Staab D, Zychlinsky A (2011) Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS One 6(12):e28526. doi: 10.1371/journal.pone.0028526
15. Feldman C (2012) The use of anti-inflammatory therapy and macrolides in bronchiectasis. Clin Chest Med 33(2):371-380
16. Aldridge AJ (2002) Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168(4):204-214
17. Kovach MA, Standiford TJ (2012) The function of neutrophils in sepsis. Curr Opin Infect Dis 25(3):321-327
18. Kennedy AD, DeLeo FR (2009) Neutrophil apoptosis and the resolution of infection. Immunol Res 43(1-3):25-61
19. Galani V, Tatsiki E, Bai M, Kitsoulis P, Lekka M, Nakos G, Kanavaros P (2009) The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): An up-to-date cell-specific review. Pathol Res Pract 206(3):145-150
20. Németh T, Mócsai A (2012) The role of neutrophils in autoimmune diseases. Immunol Lett 143(1):9-19
21. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73):73ra19. doi: 10.1126/scitranslmed.3001180
22. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73):73ra20. doi: 10.1126/scitranslmed.3001201
23. Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between inflammation and cancer. Curr Pharm Res 18(26):3831-3852
24. Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76(4):655-663
25. Knaapen AM, Güngör N, Schins PF, Borm PJA, Van Schooten FJ (2006) Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21(4):225-236
26. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, Ufman LH, Leenen LP, Pickkers P, Koenderman L (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122(1):327-336
27. Verbeke H, Geboes K, Van Damme J, Struyf S (2012) The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 1825(1):117-129
28. Verbeke H, Struyf S, Laureys G, Van Damme J (2011) The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev 22(5-6):345-358
29. Tintinger G, Steel HC, Anderson R (2005) Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control. Clin Exp Immunol 141(2):191-200
30. Babior BM (2004) NADPH oxidase. Curr Opin Immunol 16:42-47
31. Weiss SJ (1989) Tissue destruction by neutrophils. NEJM 320:365-376
32. Janoff A (1985) Elastase and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 132:417-433
33. Yamamori T, Inanami O, Nagahata H, Cui Y-D, Kuwabara M (2000) Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett 467:253-258
34. 2+ signaling requirements. Biochem J 337:153-169
35. 2+ entry. Nat Cell Biol 11:669-677
36. 2+ by chemoattractant-activated human neutrophils. Biochem Pharmacol 67:2263-2271
37. Ohnishi H, Miyahara N, Gelfand EW (2008) The role of leukotriene B4 in allergic diseases. Allergol Int 57(4):291-298
38. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM (2006) Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 203(4):837-842
39. Mathis S, Jala VR, Haribabu B (2007) Role of leukotriene B4 receptors in rheumatoid arthritis. Autoimmun Rev 7(1):12-17
40. Nam YH, Min A, Kim SH, Lee YA, Kim KA, Song KJ, Shin MH (2012) Leukotriene B(4) receptors BLT1 and BLT2 are involved in interleukin-8 production in human neutrophils induced by Trichomonas vaginalis-derived secretory products. Inflamm Res 61(2):97-102
41. Steel HC, Tintinger GR, Theron AJ, Anderson R (2007) Itraconazole- mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils due to interference with production of leukotriene B4. Clin Exp Immunol 150(1):144-150
42. 2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochem Biophys Acta 1771(9):1235-1245
43. 2. J Immunol 188(1):21-28
44. 2 and the suppression of phagocyte innate immune responses in different organs. Mediat Inflamm 2012:327568
45. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA (2008) Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 105(11):4335-4339
46. Koppe U, Suttorp N, Opitz B (2012) Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 14(4):460-466
47. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Cell 32(4):157-164
48. Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatol 49(9):1618-1631
49. Ma X, Chang W, Zhang C, Zhou X, Yu F (2012) Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils. PLoS One 7(4):e34970
50. Cockeran R, Durandt C, Feldman C, Mitchell TJ, Anderson R (2002) Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186(4):562-565
51. Tamassia N, Bazzoni F, Le Moigne V, Calzetti F, Masala C, Grisendi G, Bussmeyer U, Scutera S, De Gironcoli M, Costantini C, Musso T, Cassatella MA (2012) IFN-β expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling. J Immunol 189(3):1500-1509
52. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA (2000) The neutrophil as a cellular source of chemokines. Immunol Rev 177:195-203
53. Holzinger D, Gieldon L, Mysore V, Nippe N, Taxman DJ, Duncan JA, Broglie PM, Marketon K, Austermann J, Vogl T, Foell D, Niemann S, Peters G, Roth J, Löffler B (2012) Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol 92(5):1069-1081
54. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Pétrilli V, Andrew PW, Kadioglu A, Lavelle EC (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6(11):e1001191
55. Elbim C, Estaquier J (2010) Cytokines modulate neutrophil death. Eur Cytokine Netw 21(1):1-6
56. Barnes PJ (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163(1):29-43
57. Hirsch G, Lavoie-Lamoureux A, Beauchamp G, Lavoie J-P (2012) Neutrophils are not less sensitive than other blood leukocytes to the genomic effects of glucocorticoids. PLoS One 7(9):e44606
58. Barnes PJ (2007) New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119(5):1055-1062
59. Barnes PJ (2012) Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 129(1):48-59
60. Sivertson KL, Seeds MC, Long DL, Peachman KK, Bass DA (2007) The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils. Cell Immunol 246(1):34-45
61. Madsen-Bouterse SA, Rosa GJM, Burton JL (2006) Glucocorticoid modulation of Bcl-2 family members A1 and Bak during delayed spontaneous apoptosis of bovine blood neutrophils. Endocrinol 147(8):3826-3834
62. Saffar AS, Dragon S, Ezzati P, Shan L, Gounni AS (2008) Phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils. J Allergy Clin Immunol 121(2):492-498
63. 4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J Immunol 168(7):3570-3576
64. Strickland I, Kisich H, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DYM (2001) High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193(5):585-593
65. Vazquez-Tello A, Semlali A, Chakir J, Martin JG, Leung DY, Eidelman DH, Hamid Q (2010) Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy 40(9):1312-1322
66. Zijlstra GJ, ten Hacken NH, Hoffmann RF, van Oosterhout AJ, Heijink IH (2012) Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur Respir J 39(2):439-445
67. Mercado N, Hakim A, Kobayashi Y, Meah S, Usmani OS, Chung KF, Barnes PJ, Ito K (2012) Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS One 7(7):e41582
68. Schleimer RP, Freeland HS, Peters SP, Brown KE, Derse CP (1989) An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 250(2):598-605
69. Gravett CM, Theron AJ, Steel HC, Tintinger GR, Cockeran R, Feldman C, Anderson R (2010) Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. Eur Respir J 36(6):1417-1424
70. Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C (2012) Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediat Inflamm 2012:584262
71. Aoshiba K, Nagai A, Komo K (1997) Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 39(4):872-877
72. Feldman C, Anderson R (2005) The cytoprotective interactions of antibiotics with human ciliated airway epithelium. In: Rubin BK, Tamaoki (eds) Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. Birkhauser, Basel, pp 49-63
73. Tsuchihashi Y, Oishi K, Yoshimine H, Suzuki S, Kumatori A, Sunazuka T, Omura S, Matsushima K, Nagatake T (2002) Fourteen-member macrolides suppress interleukin-8 production but do not promote apoptosis of activated neutrophils. Antimicrob Agents Chemother 46(4):1101-1104
74. Vanaudenaerde BM, Wuyts WA, Geudens N, Dupont LJ, Schoofs K, Smeets S, Van Raemdonck DE, Verleden GM (2007) Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 7(1):76-82
75. Li M, Zhong X, He Z, Wen M, Li J, Peng X, Liu G, Deng J, Zhang J, Bai J (2012) Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB acvtivity in human macrophages in vitro. Int Immunopharmacol 12(4):643-650
76. Tintinger GR, Anderson R, Theron AJ, Ramafi G, Ker JA (2000) Comparison of the effects of selective and non-selective beta-adrenergic agonists on the pro-inflammatory activities of human neutrophils in vitro. Inflamm 24:239-249
77. Barletta KE, Ley K, Mehrad B (2012) Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol 32:856-864
78. Torphy TJ (1998) Phosphodiesterase enzymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157:351-370
79. Anderson R, Theron AJ, Gravett CM, Steel HC, Tintinger GR, Feldman C (2009) Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 156:105-115
80. Gravett CM, Tintinger GR, Theron AJ, Anderson R, Feldman C, Green R (2010) Montelukast sodium: administration to children to control intermittent asthma. Clin Med Rev Ther 2:1-10
81. Tintinger GR, Feldman C, Theron AJ, Anderson R (2010) Montelukast: more than a cysteinyl leukotriene receptor antagonist? Sci World J 10:2403-2413
82. Hatzelmann A, Schudt C (2001) Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther 297:267-279
83. Vignola AM (2004) PDE4 inhibitors in COPD - a more selective approach to treatment. Respir Med 98:495-503
84. Tannheimer SL, Sorensen EA, Haran AC, Mansfield CN, Wright CD, Salmon M (2012) Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells. Pulm Pharmacol Ther 25(2):178-184
85. Tintinger GR, Steel HC, Theron AJ, Anderson R (2009) Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes. Drug Des Dev Ther 2:95-104
86. Steel HC, Tintinger GR, Anderson R (2008) Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure. Chem Biol Drug Des 72(3):225-228
87. Steel HC, Theron AJ, Tintinger GR, Anderson R (2009) Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant- activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation. J Antimicrob Chemother 64(5):1008-1012
88. Ramires R, Caiaffa ME, Tursi A, Haeggström JZ, Macchia L (2004) Novel inhibitory effects on 5-lipoxygenase activity by the anti-asthma drug montelukast. Biochem Biophys Res Comm 324(2):815-821
89. Woszczek G, Chen LY, Alsaaty S, Nagineni S, Shelhamer JH (2010) Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. J Immunol 184(4):2219-2225
90. Theron AJ, Gravett CM, Steel HC, Tintinger GR, Feldman C, Anderson R (2009) Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants. Inflamm Res 58(5):263-268
91. Serezani CH, Ballinger MN, Aranoff DM, Peters-Golden M (2008) Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 39(2):127-132
92. Stables MJ, Gilroy DW (2011) Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res 50(1):35-51
93. Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, Stryszak P, Gann L, Sadeh J, Chanez P (2012) Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy 42(7):1097-1103
94. Moss RB, Mistry SJ, Konstan MW, Pilewski JM, Kerem E, Tal-Singer R, Lazaar AL (2013) Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. J Cyst Fibros. doi: 10.1016/j.jcf.2012.08.016
95. Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, Chen C, Tal-Singer R (2011) SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol 72(2):282-293
96. Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ (2012) The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther 11(6):1353-1364
97. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ, Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Uveitis Study Group, Rose K, Haider A, Di Padova F (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2(52):52ra72
98. Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366(13):1190-1199
99. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JGB, Kricorian G, Aras G, Li J, Russell CB, Thompson EH, Baumgartner S (2012) Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 366(13):1181-1189
100. Miossec P, Kolls JK (2012) Targeting IL-17 and T(H)17 cells in chronic inflammation. Nat Rev Drug Discov 11(10):763-776
101. Huang H-Y, Caballero B, Chang S, Alberg AJ, Semba RD et al (2006) The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health State-of-the-Science Conference. Ann Intern Med 145:372-385
102. Tintinger GR, Theron AJ, Steel HC, Anderson R (2000) Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease. Clin Exp Immunol 123:254-263